Issue 5/2018
Content (17 Articles)
Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population
Minkyo Song, M. Constanza Camargo, Stephanie J. Weinstein, Ana F. Best, Satu Männistö, Demetrius Albanes, Charles S. Rabkin
Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.S.
Thomas Abrams, Lisa M. Hess, Yajun Emily Zhu, William Schelman, Astra M. Liepa, Charles Fuchs
Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication
Masahiro Maeda, Satoshi Yamashita, Taichi Shimazu, Naoko Iida, Hideyuki Takeshima, Takeshi Nakajima, Ichiro Oda, Sohachi Nanjo, Chika Kusano, Akiko Mori, Hiroshi Moro, Harumi Yamada, Shoichiro Tsugane, Toshiro Sugiyama, Yoshiharu Sakai, Toshikazu Ushijima
HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells
Meng Xue, Lu-yi Chen, Wei-jia Wang, Ting-ting Su, Liu-hong Shi, Lan Wang, Wen Zhang, Jian-min Si, Liang-jing Wang, Shu-jie Chen
Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status
Tamotsu Sugai, Makoto Eizuka, Noriyuki Arakawa, Mitsumasa Osakabe, Wataru Habano, Yasuko Fujita, Eiichiro Yamamoto, Hiroo Yamano, Masaki Endoh, Takayuki Matsumoto, Hiromu Suzuki
Quantitative assessment of fluorescence intensity of ICG in sentinel nodes in early gastric cancer
Keishi Okubo, Yoshikazu Uenosono, Takaaki Arigami, Daisuke Matsushita, Shigehiro Yanagita, Takashi Kijima, Masahiko Amatatsu, Sumiya Ishigami, Kosei Maemura, Shoji Natsugoe
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Zhihao Lu, Xiaotian Zhang, Wei Liu, Tianshu Liu, Bing Hu, Wei Li, Qingxia Fan, Jianming Xu, Nong Xu, Yuxian Bai, Yueyin Pan, Qing Xu, Wei Bai, Li Xia, Yong Gao, Wenling Wang, Yongqian Shu, Lin Shen
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study
Akitaka Makiyama, Kenji Kunieda, Masaaki Noguchi, Takeshi Kajiwara, Takao Tamura, Koji Takeda, Junko Sugiyama, Keiko Minashi, Toshikazu Moriwaki, Naotoshi Sugimoto, Michitaka Nagase, Yuji Negoro, Takashi Tsuda, Hideki Shimodaira, Naohiro Okano, Akihito Tsuji, Daisuke Sakai, Kazuhiro Yanagihara, Shinya Ueda, Shingo Tamura, Satoshi Otsu, Takuya Honda, Yuzo Matsushita, Tatsuya Okuno, Tomomi Kashiwada, Akira Nozaki, Masahide Ebi, Hiroyuki Okuda, Mototsugu Shimokawa, Shuichi Hironaka, Ichinosuke Hyodo, Eishi Baba, Narikazu Boku, Kei Muro, Taito Esaki
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11
Hyeong Su Kim, Min-Hee Ryu, Dae Young Zang, Sook Ryun Park, Boram Han, Won Ki Kang, Sun Young Rha, Minkyu Jung, Jin-Soo Kim, Byung Woog Kang, Kyung-Hee Lee, Sang-Young Rho, Jung Han Kim, Kab Choong Kim, Ji Woong Cho, Dae Ro Choi, Hyun Lim, Ho Suk Kang, Jae Seung Soh, Min-Jeong Kim, Jinwon Seo, Yoon-Koo Kang
A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial
Kazuhiro Nishikawa, Akira Tsuburaya, Takaki Yoshikawa, Masazumi Takahashi, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Toru Aoyama, Yasushi Rino, Junji Kawada, Akihito Tsuji, Koichi Taira, Yutaka Kimura, Yasuhiro Kodera, Yoshinori Hirashima, Hiroshi Yabusaki, Naoki Hirabayashi, Kazumasa Fujitani, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)
Minkyu Jung, Min-Hee Ryu, Do Youn Oh, Myounghee Kang, Dae Young Zang, In Gyu Hwang, Keun-Wook Lee, Ki Hyang Kim, Byoung Yong Shim, Eun Kee Song, Sun Jin Sym, Hye Sook Han, Young Lee Park, Jin Soo Kim, Hyun Woo Lee, Moon Hee Lee, Dong-Hoe Koo, Hong Suk Song, Namsu Lee, Sung Hyun Yang, Dae Ro Choi, Young Seon Hong, Kyoung Eun Lee, Chi Hoon Maeng, Jin Ho Baek, Samyong Kim, Yeul Hong Kim, Sun Young Rha, Jae Yong Cho, Yoon-Koo Kang
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices
A. Scott Paulson, Lisa M. Hess, Astra M. Liepa, Zhanglin Lin Cui, Kathleen M. Aguilar, Jamyia Clark, William Schelman
Total vs proximal gastrectomy for adenocarcinoma of the upper third of the stomach: a propensity-score-matched analysis of a multicenter western experience (On behalf of the Italian Research Group for Gastric Cancer–GIRCG)
Fausto Rosa, Giuseppe Quero, Claudio Fiorillo, Massimiliano Bissolati, Chiara Cipollari, Stefano Rausei, Damiano Chiari, Laura Ruspi, Giovanni de Manzoni, Guido Costamagna, Giovanni Battista Doglietto, Sergio Alfieri
Which method is more suitable for advanced gastric cancer with enlarged lymph nodes, laparoscopic radical gastrectomy or open gastrectomy?
Qi-Yue Chen, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jian-Xian Lin, Jun Lu, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ze-Ning Huang, Ju-Li Lin, Chang-Ming Huang
Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis
Chun-Chao Zhu, Tae-Han Kim, Felix Berlth, Shin-Hoo Park, Yun-Suhk Suh, Seong-Ho Kong, Hyuk-Joon Lee, Hui Cao, Han-Kwang Yang
Two-point measurement of amylase in drainage fluid predicts severe postoperative pancreatic fistula after gastric cancer surgery
Satoshi Kamiya, Naoki Hiki, Koshi Kumagai, Michitaka Honda, Souya Nunobe, Manabu Ohashi, Takeshi Sano, Toshiharu Yamaguchi
Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS)
Zhining Liu, Weidong Ren, Jintao Guo, Ying Zhao, Siyu Sun, Yuhong Li, Zhijun Liu